These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Antiglycopeptide Mouse Monoclonal Antibody LpMab-21 Exerts Antitumor Activity Against Human Podoplanin Through Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity. Kato Y; Kunita A; Fukayama M; Abe S; Nishioka Y; Uchida H; Tahara H; Yamada S; Yanaka M; Nakamura T; Saidoh N; Yoshida K; Fujii Y; Honma R; Takagi M; Ogasawara S; Murata T; Kaneko MK Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):20-24. PubMed ID: 28234556 [TBL] [Abstract][Full Text] [Related]
29. A novel anti-EGFR monoclonal antibody (EMab-17) exerts antitumor activity against oral squamous cell carcinomas via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. Takei J; Kaneko MK; Ohishi T; Kawada M; Harada H; Kato Y Oncol Lett; 2020 Apr; 19(4):2809-2816. PubMed ID: 32218834 [TBL] [Abstract][Full Text] [Related]
30. An anti‑TROP2 monoclonal antibody TrMab‑6 exerts antitumor activity in breast cancer mouse xenograft models. Tanaka T; Ohishi T; Asano T; Takei J; Nanamiya R; Hosono H; Sano M; Harada H; Kawada M; Kaneko MK; Kato Y Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34013368 [TBL] [Abstract][Full Text] [Related]
31. A cancer-specific anti-podocalyxin monoclonal antibody (60-mG Kaneko MK; Ohishi T; Kawada M; Kato Y Biochem Biophys Rep; 2020 Dec; 24():100826. PubMed ID: 33088928 [TBL] [Abstract][Full Text] [Related]
32. Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin. Kato Y; Mizuno T; Yamada S; Nakamura T; Itai S; Yanaka M; Sano M; Kaneko MK Monoclon Antib Immunodiagn Immunother; 2018 Nov; 37(5):218-223. PubMed ID: 30362926 [TBL] [Abstract][Full Text] [Related]
33. A Humanized and Defucosylated Antibody against Podoplanin (humLpMab-23-f) Exerts Antitumor Activities in Human Lung Cancer and Glioblastoma Xenograft Models. Suzuki H; Ohishi T; Kaneko MK; Kato Y Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894446 [TBL] [Abstract][Full Text] [Related]
34. Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma. Asano T; Ohishi T; Takei J; Nakamura T; Nanamiya R; Hosono H; Tanaka T; Sano M; Harada H; Kawada M; Kaneko MK; Kato Y Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184091 [TBL] [Abstract][Full Text] [Related]
35. Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity. Kaneko MK; Yamada S; Nakamura T; Abe S; Nishioka Y; Kunita A; Fukayama M; Fujii Y; Ogasawara S; Kato Y Cancer Med; 2017 Apr; 6(4):768-777. PubMed ID: 28332312 [TBL] [Abstract][Full Text] [Related]
36. Antipodoplanin antibody enhances the antitumor effects of CTLA-4 blockade against malignant mesothelioma by natural killer cells. Yoneda H; Mitsuhashi A; Yoshida A; Ogino H; Itakura S; Nguyen NT; Nokihara H; Sato S; Shinohara T; Hanibuchi M; Abe S; Kaneko MK; Kato Y; Nishioka Y Cancer Sci; 2024 Feb; 115(2):357-368. PubMed ID: 38148492 [TBL] [Abstract][Full Text] [Related]
37. Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potency. Yang Y; Guo Q; Xia M; Li Y; Peng X; Liu T; Tong X; Xu J; Guo H; Qian W; Hou S; Dai J; Wang H; Liu R; Guo Y MAbs; 2015; 7(2):440-50. PubMed ID: 25679409 [TBL] [Abstract][Full Text] [Related]
38. Development of Monoclonal Antibody 281-mG Nanamiya R; Suzuki H; Takei J; Li G; Goto N; Harada H; Saito M; Tanaka T; Asano T; Kaneko MK; Kato Y Monoclon Antib Immunodiagn Immunother; 2022 Dec; 41(6):311-319. PubMed ID: 35483059 [TBL] [Abstract][Full Text] [Related]